Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis

Area of Science:

• Nephrology
• Biochemistry
• Dialysis Therapy

Background:

• Serum beta-2 microglobulin (s beta 2M) is a marker of renal function and inflammation.
• Peritoneal dialysis (PD) is a treatment for end-stage renal disease, but residual renal function (RRF) can vary.
• Understanding factors influencing s beta 2M in PD patients is crucial for patient management.

Purpose of the Study:

• To investigate the correlation between serum beta-2 microglobulin (s beta 2M) levels and various markers of renal function and dialysis adequacy in noncirrhotic patients undergoing peritoneal dialysis.
• To determine the relative contribution of residual renal function versus peritoneal clearance in controlling s beta 2M levels.

Main Methods:

• Cross-sectional study involving 32 noncirrhotic patients on peritoneal dialysis.
• Measurement of serum beta-2 microglobulin (s beta 2M).
• Assessment of serum creatinine (sCr), blood urea nitrogen (BUN), creatinine and BUN clearance, 24-hour Kt/V, glomerular filtration rate (GFR), 24-hour urine output, serum total protein, and beta 2M peritoneal clearance and mass transfer.

Main Results:

• Significant positive correlations were observed between s beta 2M and sCr, BUN, creatinine and BUN clearance, 24-hour Kt/V, GFR, 24-hour urine output, and serum total protein (p < 0.01).
• s beta 2M also showed significant correlations with peritoneal clearance and mass transfer (p < 0.05).
• Residual renal function markers demonstrated stronger correlations with s beta 2M than peritoneal clearance parameters.

Conclusions:

• Residual renal function plays a significant role in determining serum beta-2 microglobulin levels in patients on peritoneal dialysis.
• The contribution of residual renal function to s beta 2M regulation appears to be more substantial than that of beta 2M peritoneal clearance.
• Preserving residual renal function is important for managing s beta 2M levels in PD patients.